Susquehanna International Group’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-14,949
| Closed | -$52.9K | – | 6874 |
|
2025
Q1 | $52.9K | Sell |
14,949
-11,352
| -43% | -$40.2K | ﹤0.01% | 6003 |
|
2024
Q4 | $83.9K | Buy |
26,301
+4,420
| +20% | +$14.1K | ﹤0.01% | 5740 |
|
2024
Q3 | $80.3K | Sell |
21,881
-37,878
| -63% | -$139K | ﹤0.01% | 5182 |
|
2024
Q2 | $279K | Buy |
59,759
+33,975
| +132% | +$159K | ﹤0.01% | 4309 |
|
2024
Q1 | $227K | Buy |
+25,784
| New | +$227K | ﹤0.01% | 4543 |
|
2023
Q3 | – | Sell |
-10,581
| Closed | -$59.7K | – | 6014 |
|
2023
Q2 | $59.7K | Buy |
+10,581
| New | +$59.7K | ﹤0.01% | 5166 |
|
2022
Q4 | – | Sell |
-14,558
| Closed | -$70K | – | 6381 |
|
2022
Q3 | $70K | Buy |
+14,558
| New | +$70K | ﹤0.01% | 5406 |
|
2022
Q1 | – | Sell |
-10,439
| Closed | -$83K | – | 6201 |
|
2021
Q4 | $83K | Sell |
10,439
-470
| -4% | -$3.74K | ﹤0.01% | 5346 |
|
2021
Q3 | $122K | Buy |
+10,909
| New | +$122K | ﹤0.01% | 4915 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 5678 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 5511 |
|